angiotensinogen has been researched along with Sarcopenia* in 2 studies
2 other study(ies) available for angiotensinogen and Sarcopenia
Article | Year |
---|---|
Correlation between the 24-h urinary angiotensinogen or aldosterone level and muscle mass: Japan shimanami health promoting program study.
Our previous report indicated that sarcopenia is associated with arterial stiffness and cardiovascular death. The renin-angiotensin system (RAS) plays an important role in cardiovascular disease and its activation may be correlated with sarcopenia according to basic research. However, few clinical studies have assessed the correlation between skeletal muscle loss and RAS component concentrations in healthy subjects. The purpose of this study was to investigate the relationships between the excretion of angiotensinogen (AGT) and aldosterone (Ald) in 24-h urine samples and clinical and sarcopenic indices. A total of 344 people participated in a voluntary medical check-up program, "Anti-Aging Doc", and underwent measurement of their sarcopenia-related indices. Urine samples were collected for 24-h within 8 weeks after a medical check-up using a partition cup and a proportional sampling method. Urine AGT and Ald levels were evaluated by enzyme-linked immunosorbent assay (ELISA). After compensating for possible confounding parameters, including baPWV, the 24-h urinary excretion of AGT was independently and negatively associated with the thigh muscle cross-sectional area. On the other hand, urinary Ald excretion was not associated with sarcopenia-related indices after compensation, even though it showed a modest but significantly positive association with sarcopenic indices in single regression analysis. Urinary AGT was related to sarcopenic indices and may be involved in the pathogenesis of sarcopenia. On the other hand, urinary Ald was not related to sarcopenic indices when considering other risk factors. Topics: Aged; Aged, 80 and over; Aldosterone; Anatomy, Cross-Sectional; Angiotensinogen; Electric Impedance; Female; Hand Strength; Health Promotion; Healthy Aging; Humans; Japan; Male; Middle Aged; Muscle, Skeletal; Renin-Angiotensin System; Risk Factors; Sarcopenia | 2018 |
Proteomics Analysis to Identify and Characterize the Biomarkers and Physical Activities of Non-Frail and Frail Older Adults.
Globally, the proportion of older adults is increasing. Older people face chronic conditions such as sarcopenia and functional decline, which are often associated with disability and frailty. Proteomics assay of potential serum biomarkers of frailty in older adults. Older adults were divided into non-frail and frail groups ( Topics: Adult; Aged; Aged, 80 and over; Aging; Angiotensinogen; Antithrombin III; Biomarkers; Exercise; Female; Frail Elderly; Hand Strength; Humans; Kininogens; Male; Proteomics; Sarcopenia | 2017 |